Clinical Trial Update: Short-term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the short-term behavioral effects of cholesterol therapy in Smith-Lemli-Opitz Syndrome has completed and results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smith-lemli-opitz Syndrome

Drugs mentioned

• Cholesterol therapy (cholesterol supplementation)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Smith-Lemli-Opitz Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2014-04-09